Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Nuclear Medicine market report explains the definition, types, applications, major countries, and major players of the Nuclear Medicine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Bayer
Eli Lilly
Nordion
SIEMENS
Mallinckrodt
Bracco Imaging
Lantheus Medical Imaging
China Isotope & Radiation
GE Healthcare
Jubilant Pharma
Yantai Dongcheng Biochemicals
By Type:
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Other
By End-User:
Diagnostic
Therapeutic
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Nuclear Medicine Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Nuclear Medicine Outlook to 2028- Original Forecasts
-
2.2 Nuclear Medicine Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Nuclear Medicine Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Nuclear Medicine Market- Recent Developments
-
6.1 Nuclear Medicine Market News and Developments
-
6.2 Nuclear Medicine Market Deals Landscape
7 Nuclear Medicine Raw Materials and Cost Structure Analysis
-
7.1 Nuclear Medicine Key Raw Materials
-
7.2 Nuclear Medicine Price Trend of Key Raw Materials
-
7.3 Nuclear Medicine Key Suppliers of Raw Materials
-
7.4 Nuclear Medicine Market Concentration Rate of Raw Materials
-
7.5 Nuclear Medicine Cost Structure Analysis
-
7.5.1 Nuclear Medicine Raw Materials Analysis
-
7.5.2 Nuclear Medicine Labor Cost Analysis
-
7.5.3 Nuclear Medicine Manufacturing Expenses Analysis
8 Global Nuclear Medicine Import and Export Analysis (Top 10 Countries)
-
8.1 Global Nuclear Medicine Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Nuclear Medicine Export by Region (Top 10 Countries) (2017-2028)
9 Global Nuclear Medicine Market Outlook by Types and Applications to 2022
-
9.1 Global Nuclear Medicine Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Tc-99 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global I-123/131 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global In-111 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Xe-133 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Th-201 Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Ga-67 Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Nuclear Medicine Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Diagnostic Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Therapeutic Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Nuclear Medicine Market Analysis and Outlook till 2022
-
10.1 Global Nuclear Medicine Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Nuclear Medicine Consumption (2017-2022)
-
10.2.2 Canada Nuclear Medicine Consumption (2017-2022)
-
10.2.3 Mexico Nuclear Medicine Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Nuclear Medicine Consumption (2017-2022)
-
10.3.2 UK Nuclear Medicine Consumption (2017-2022)
-
10.3.3 Spain Nuclear Medicine Consumption (2017-2022)
-
10.3.4 Belgium Nuclear Medicine Consumption (2017-2022)
-
10.3.5 France Nuclear Medicine Consumption (2017-2022)
-
10.3.6 Italy Nuclear Medicine Consumption (2017-2022)
-
10.3.7 Denmark Nuclear Medicine Consumption (2017-2022)
-
10.3.8 Finland Nuclear Medicine Consumption (2017-2022)
-
10.3.9 Norway Nuclear Medicine Consumption (2017-2022)
-
10.3.10 Sweden Nuclear Medicine Consumption (2017-2022)
-
10.3.11 Poland Nuclear Medicine Consumption (2017-2022)
-
10.3.12 Russia Nuclear Medicine Consumption (2017-2022)
-
10.3.13 Turkey Nuclear Medicine Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Nuclear Medicine Consumption (2017-2022)
-
10.4.2 Japan Nuclear Medicine Consumption (2017-2022)
-
10.4.3 India Nuclear Medicine Consumption (2017-2022)
-
10.4.4 South Korea Nuclear Medicine Consumption (2017-2022)
-
10.4.5 Pakistan Nuclear Medicine Consumption (2017-2022)
-
10.4.6 Bangladesh Nuclear Medicine Consumption (2017-2022)
-
10.4.7 Indonesia Nuclear Medicine Consumption (2017-2022)
-
10.4.8 Thailand Nuclear Medicine Consumption (2017-2022)
-
10.4.9 Singapore Nuclear Medicine Consumption (2017-2022)
-
10.4.10 Malaysia Nuclear Medicine Consumption (2017-2022)
-
10.4.11 Philippines Nuclear Medicine Consumption (2017-2022)
-
10.4.12 Vietnam Nuclear Medicine Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Nuclear Medicine Consumption (2017-2022)
-
10.5.2 Colombia Nuclear Medicine Consumption (2017-2022)
-
10.5.3 Chile Nuclear Medicine Consumption (2017-2022)
-
10.5.4 Argentina Nuclear Medicine Consumption (2017-2022)
-
10.5.5 Venezuela Nuclear Medicine Consumption (2017-2022)
-
10.5.6 Peru Nuclear Medicine Consumption (2017-2022)
-
10.5.7 Puerto Rico Nuclear Medicine Consumption (2017-2022)
-
10.5.8 Ecuador Nuclear Medicine Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Nuclear Medicine Consumption (2017-2022)
-
10.6.2 Kuwait Nuclear Medicine Consumption (2017-2022)
-
10.6.3 Oman Nuclear Medicine Consumption (2017-2022)
-
10.6.4 Qatar Nuclear Medicine Consumption (2017-2022)
-
10.6.5 Saudi Arabia Nuclear Medicine Consumption (2017-2022)
-
10.6.6 United Arab Emirates Nuclear Medicine Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Nuclear Medicine Consumption (2017-2022)
-
10.7.2 South Africa Nuclear Medicine Consumption (2017-2022)
-
10.7.3 Egypt Nuclear Medicine Consumption (2017-2022)
-
10.7.4 Algeria Nuclear Medicine Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Nuclear Medicine Consumption (2017-2022)
-
10.8.2 New Zealand Nuclear Medicine Consumption (2017-2022)
11 Global Nuclear Medicine Competitive Analysis
-
11.1 Bayer
-
11.1.1 Bayer Company Details
-
11.1.2 Bayer Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Bayer Nuclear Medicine Main Business and Markets Served
-
11.1.4 Bayer Nuclear Medicine Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Eli Lilly
-
11.2.1 Eli Lilly Company Details
-
11.2.2 Eli Lilly Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Eli Lilly Nuclear Medicine Main Business and Markets Served
-
11.2.4 Eli Lilly Nuclear Medicine Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Nordion
-
11.3.1 Nordion Company Details
-
11.3.2 Nordion Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Nordion Nuclear Medicine Main Business and Markets Served
-
11.3.4 Nordion Nuclear Medicine Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 SIEMENS
-
11.4.1 SIEMENS Company Details
-
11.4.2 SIEMENS Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 SIEMENS Nuclear Medicine Main Business and Markets Served
-
11.4.4 SIEMENS Nuclear Medicine Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Mallinckrodt
-
11.5.1 Mallinckrodt Company Details
-
11.5.2 Mallinckrodt Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Mallinckrodt Nuclear Medicine Main Business and Markets Served
-
11.5.4 Mallinckrodt Nuclear Medicine Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Bracco Imaging
-
11.6.1 Bracco Imaging Company Details
-
11.6.2 Bracco Imaging Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Bracco Imaging Nuclear Medicine Main Business and Markets Served
-
11.6.4 Bracco Imaging Nuclear Medicine Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Lantheus Medical Imaging
-
11.7.1 Lantheus Medical Imaging Company Details
-
11.7.2 Lantheus Medical Imaging Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Lantheus Medical Imaging Nuclear Medicine Main Business and Markets Served
-
11.7.4 Lantheus Medical Imaging Nuclear Medicine Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 China Isotope & Radiation
-
11.8.1 China Isotope & Radiation Company Details
-
11.8.2 China Isotope & Radiation Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 China Isotope & Radiation Nuclear Medicine Main Business and Markets Served
-
11.8.4 China Isotope & Radiation Nuclear Medicine Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 GE Healthcare
-
11.9.1 GE Healthcare Company Details
-
11.9.2 GE Healthcare Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 GE Healthcare Nuclear Medicine Main Business and Markets Served
-
11.9.4 GE Healthcare Nuclear Medicine Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Jubilant Pharma
-
11.10.1 Jubilant Pharma Company Details
-
11.10.2 Jubilant Pharma Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Jubilant Pharma Nuclear Medicine Main Business and Markets Served
-
11.10.4 Jubilant Pharma Nuclear Medicine Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Yantai Dongcheng Biochemicals
-
11.11.1 Yantai Dongcheng Biochemicals Company Details
-
11.11.2 Yantai Dongcheng Biochemicals Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Yantai Dongcheng Biochemicals Nuclear Medicine Main Business and Markets Served
-
11.11.4 Yantai Dongcheng Biochemicals Nuclear Medicine Product Portfolio
-
11.11.5 Recent Research and Development Strategies
12 Global Nuclear Medicine Market Outlook by Types and Applications to 2028
-
12.1 Global Nuclear Medicine Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Tc-99 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global I-123/131 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global In-111 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Xe-133 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Th-201 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.6 Global Ga-67 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.7 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Nuclear Medicine Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Diagnostic Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Therapeutic Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Nuclear Medicine Market Analysis and Outlook to 2028
-
13.1 Global Nuclear Medicine Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Nuclear Medicine Consumption Forecast (2022-2028)
-
13.2.2 Canada Nuclear Medicine Consumption Forecast (2022-2028)
-
13.2.3 Mexico Nuclear Medicine Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Nuclear Medicine Consumption Forecast (2022-2028)
-
13.3.2 UK Nuclear Medicine Consumption Forecast (2022-2028)
-
13.3.3 Spain Nuclear Medicine Consumption Forecast (2022-2028)
-
13.3.4 Belgium Nuclear Medicine Consumption Forecast (2022-2028)
-
13.3.5 France Nuclear Medicine Consumption Forecast (2022-2028)
-
13.3.6 Italy Nuclear Medicine Consumption Forecast (2022-2028)
-
13.3.7 Denmark Nuclear Medicine Consumption Forecast (2022-2028)
-
13.3.8 Finland Nuclear Medicine Consumption Forecast (2022-2028)
-
13.3.9 Norway Nuclear Medicine Consumption Forecast (2022-2028)
-
13.3.10 Sweden Nuclear Medicine Consumption Forecast (2022-2028)
-
13.3.11 Poland Nuclear Medicine Consumption Forecast (2022-2028)
-
13.3.12 Russia Nuclear Medicine Consumption Forecast (2022-2028)
-
13.3.13 Turkey Nuclear Medicine Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Nuclear Medicine Consumption Forecast (2022-2028)
-
13.4.2 Japan Nuclear Medicine Consumption Forecast (2022-2028)
-
13.4.3 India Nuclear Medicine Consumption Forecast (2022-2028)
-
13.4.4 South Korea Nuclear Medicine Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Nuclear Medicine Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Nuclear Medicine Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Nuclear Medicine Consumption Forecast (2022-2028)
-
13.4.8 Thailand Nuclear Medicine Consumption Forecast (2022-2028)
-
13.4.9 Singapore Nuclear Medicine Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Nuclear Medicine Consumption Forecast (2022-2028)
-
13.4.11 Philippines Nuclear Medicine Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Nuclear Medicine Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Nuclear Medicine Consumption Forecast (2022-2028)
-
13.5.2 Colombia Nuclear Medicine Consumption Forecast (2022-2028)
-
13.5.3 Chile Nuclear Medicine Consumption Forecast (2022-2028)
-
13.5.4 Argentina Nuclear Medicine Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Nuclear Medicine Consumption Forecast (2022-2028)
-
13.5.6 Peru Nuclear Medicine Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Nuclear Medicine Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Nuclear Medicine Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Nuclear Medicine Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Nuclear Medicine Consumption Forecast (2022-2028)
-
13.6.3 Oman Nuclear Medicine Consumption Forecast (2022-2028)
-
13.6.4 Qatar Nuclear Medicine Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Nuclear Medicine Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Nuclear Medicine Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Nuclear Medicine Consumption Forecast (2022-2028)
-
13.7.2 South Africa Nuclear Medicine Consumption Forecast (2022-2028)
-
13.7.3 Egypt Nuclear Medicine Consumption Forecast (2022-2028)
-
13.7.4 Algeria Nuclear Medicine Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Nuclear Medicine Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Nuclear Medicine Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Nuclear Medicine
-
Figure of Nuclear Medicine Picture
-
Table Global Nuclear Medicine Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Nuclear Medicine Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Tc-99 Consumption and Growth Rate (2017-2022)
-
Figure Global I-123/131 Consumption and Growth Rate (2017-2022)
-
Figure Global In-111 Consumption and Growth Rate (2017-2022)
-
Figure Global Xe-133 Consumption and Growth Rate (2017-2022)
-
Figure Global Th-201 Consumption and Growth Rate (2017-2022)
-
Figure Global Ga-67 Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostic Consumption and Growth Rate (2017-2022)
-
Figure Global Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure Global Nuclear Medicine Consumption by Country (2017-2022)
-
Table North America Nuclear Medicine Consumption by Country (2017-2022)
-
Figure United States Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Canada Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Mexico Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Table Europe Nuclear Medicine Consumption by Country (2017-2022)
-
Figure Germany Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure UK Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Spain Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Belgium Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure France Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Italy Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Denmark Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Finland Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Norway Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Sweden Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Poland Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Russia Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Turkey Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Table APAC Nuclear Medicine Consumption by Country (2017-2022)
-
Figure China Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Japan Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure India Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure South Korea Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Thailand Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Singapore Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Philippines Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Table South America Nuclear Medicine Consumption by Country (2017-2022)
-
Figure Brazil Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Colombia Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Chile Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Argentina Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Peru Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Table GCC Nuclear Medicine Consumption by Country (2017-2022)
-
Figure Bahrain Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Oman Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Qatar Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Table Africa Nuclear Medicine Consumption by Country (2017-2022)
-
Figure Nigeria Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure South Africa Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Egypt Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure Algeria Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Table Oceania Nuclear Medicine Consumption by Country (2017-2022)
-
Figure Australia Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Nuclear Medicine Consumption and Growth Rate (2017-2022)
-
Table Bayer Company Details
-
Table Bayer Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Nuclear Medicine Main Business and Markets Served
-
Table Bayer Nuclear Medicine Product Portfolio
-
Table Eli Lilly Company Details
-
Table Eli Lilly Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Nuclear Medicine Main Business and Markets Served
-
Table Eli Lilly Nuclear Medicine Product Portfolio
-
Table Nordion Company Details
-
Table Nordion Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nordion Nuclear Medicine Main Business and Markets Served
-
Table Nordion Nuclear Medicine Product Portfolio
-
Table SIEMENS Company Details
-
Table SIEMENS Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table SIEMENS Nuclear Medicine Main Business and Markets Served
-
Table SIEMENS Nuclear Medicine Product Portfolio
-
Table Mallinckrodt Company Details
-
Table Mallinckrodt Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mallinckrodt Nuclear Medicine Main Business and Markets Served
-
Table Mallinckrodt Nuclear Medicine Product Portfolio
-
Table Bracco Imaging Company Details
-
Table Bracco Imaging Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bracco Imaging Nuclear Medicine Main Business and Markets Served
-
Table Bracco Imaging Nuclear Medicine Product Portfolio
-
Table Lantheus Medical Imaging Company Details
-
Table Lantheus Medical Imaging Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lantheus Medical Imaging Nuclear Medicine Main Business and Markets Served
-
Table Lantheus Medical Imaging Nuclear Medicine Product Portfolio
-
Table China Isotope & Radiation Company Details
-
Table China Isotope & Radiation Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table China Isotope & Radiation Nuclear Medicine Main Business and Markets Served
-
Table China Isotope & Radiation Nuclear Medicine Product Portfolio
-
Table GE Healthcare Company Details
-
Table GE Healthcare Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table GE Healthcare Nuclear Medicine Main Business and Markets Served
-
Table GE Healthcare Nuclear Medicine Product Portfolio
-
Table Jubilant Pharma Company Details
-
Table Jubilant Pharma Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jubilant Pharma Nuclear Medicine Main Business and Markets Served
-
Table Jubilant Pharma Nuclear Medicine Product Portfolio
-
Table Yantai Dongcheng Biochemicals Company Details
-
Table Yantai Dongcheng Biochemicals Nuclear Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Yantai Dongcheng Biochemicals Nuclear Medicine Main Business and Markets Served
-
Table Yantai Dongcheng Biochemicals Nuclear Medicine Product Portfolio
-
Figure Global Tc-99 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global I-123/131 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global In-111 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Xe-133 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Th-201 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ga-67 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nuclear Medicine Consumption Forecast by Country (2022-2028)
-
Table North America Nuclear Medicine Consumption Forecast by Country (2022-2028)
-
Figure United States Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Nuclear Medicine Consumption Forecast by Country (2022-2028)
-
Figure Germany Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Nuclear Medicine Consumption Forecast by Country (2022-2028)
-
Figure China Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Nuclear Medicine Consumption Forecast by Country (2022-2028)
-
Figure Brazil Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Nuclear Medicine Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Nuclear Medicine Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Nuclear Medicine Consumption Forecast by Country (2022-2028)
-
Figure Australia Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Nuclear Medicine Consumption Forecast and Growth Rate (2022-2028)
-
